Showing results (81-90 of 233) with videos related to
Sort By:
Pageof 24
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2014
Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trialsStuart Johnson, Thomas J Louie, Dale N Gerding, et al.Infection Control and Hospital Epidemiology|June 1, 2018
Transmission of Clostridium difficile from asymptomatically colonized or infected long-term care facility residentsCurtis J Donskey, Venkata C K Sunkesula, Nimalie D Stone, et al.Anaerobe|June 11, 2018
Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015Adam Cheknis, Stuart Johnson, Laurent Chesnel, et al.Emerging Infectious Diseases|July 5, 2008
Toxinotype V Clostridium difficile in humans and food animalsMichael A Jhung, Angela D Thompson, George E Killgore, et al.Infection Control and Hospital Epidemiology|March 19, 2015
Molecular epidemiology of Clostridium difficile infections in children: a retrospective cohort studyLarry K Kociolek, Sameer J Patel, Stanford T Shulman, et al.Microbes and Infection|February 3, 2018
Comparative genomics analysis of Clostridium difficile epidemic strain DH/NAP11/106Larry K Kociolek, Dale N Gerding, David W Hecht, et al.Journal of the Pediatric Infectious Diseases Society|November 20, 2015
Concomitant Medical Conditions and Therapies Preclude Accurate Classification of Children With Severe or Severe Complicated Clostridium difficile InfectionLarry K Kociolek, Sameer J Patel, Stanford T Shulman, et al.BMC Infectious Diseases|March 13, 2022
Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trialRobert Orenstein, Erik R Dubberke, Sahil Khanna, et al.Antimicrobial Agents and Chemotherapy|August 2, 2012
Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjectsStephen A Villano, Michael Seiberling, Walter Tatarowicz, et al.Frontiers in Microbiology|January 7, 2022
Host Immune Responses to Clostridioides difficile: Toxins and BeyondBritt Nibbering, Dale N Gerding, Ed J Kuijper, et al.Pageof 24